You have 9 free searches left this month | for more free features.

Recurrent Ewing Sarcoma

Showing 1 - 25 of 9,269

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory

Active, not recruiting
  • Metastatic Ewing Sarcoma
  • +9 more
  • Cabozantinib S-malate
  • Laboratory Biomarker Analysis
  • Bordeaux, France
  • +10 more
Nov 26, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic Trial in Miami (Chemotherapy (gemcitabine & docetaxel) plus BIO-11006)

Active, not recruiting
  • Osteosarcoma Metastatic
  • Ewing's Sarcoma Metastatic
  • Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
  • Miami, Florida
    Nicklaus Children's Hospital
Nov 8, 2022

Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)

Active, not recruiting
  • Ewing Sarcoma
  • Ewing's Sarcoma Recurrent
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Ewing's Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in New York, Dallas (pbi-shRNA™ EWS/FLI1 Type 1 LPX)

Active, not recruiting
  • Ewing's Sarcoma
  • +6 more
  • pbi-shRNA™ EWS/FLI1 Type 1 LPX
  • New York, New York
  • +1 more
Mar 14, 2022

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)

Recruiting
  • Recurrent Alveolar Rhabdomyosarcoma
  • +7 more
  • Birmingham, Alabama
  • +28 more
Jan 26, 2023

Solid Tumor, Lymphoma, Osteosarcoma Trial in Orange (Surufatinib in combination with Gemcitabine)

Recruiting
  • Solid Tumor
  • +5 more
  • Surufatinib in combination with Gemcitabine
  • Orange, California
    Childrens Hospital Orange County
Feb 8, 2022

Ewing Sarcoma, Rhabdomyosarcoma Trial in Boston, Memphis (Olaparib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • Rhabdomyosarcoma
  • Boston, Massachusetts
  • +4 more
Oct 27, 2021

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

Active, not recruiting
  • Ewing Sarcoma
  • +12 more
  • Vigil
  • +2 more
  • Little Rock, Arkansas
  • +16 more
Feb 9, 2022

Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

Recruiting
  • Neuroblastoma
  • +5 more
  • GD2-CART01
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • (no location specified)
Feb 15, 2023

Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate

Recruiting
  • Recurrent or Refractory Solid Tumors
  • +4 more
  • MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
  • Cincinnati, Ohio
  • +5 more
Mar 17, 2022

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)

Not yet recruiting
  • Ewing Sarcoma
  • +3 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 27, 2023

Ewing Sarcoma, Osteosarcoma Trial in San Francisco, Aurora, Philadelphia (Cabozantinib)

Recruiting
  • Ewing Sarcoma
  • Osteosarcoma
  • San Francisco, California
  • +4 more
Nov 24, 2023

Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin

Completed
  • Refractory or Recurrent Solid Tumors
  • +3 more
  • Eribulin mesilate
  • Irinotecan hydrochloride
  • Marseille, Bouches-du-Rhône, France
  • +38 more
Jun 20, 2022

Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

Recruiting
  • Ewing Sarcoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 31, 2022

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022

Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • FoundationOne Liquid CDx
  • Los Angeles, California
  • +14 more
Oct 5, 2023